0001209191-16-121774.txt : 20160519 0001209191-16-121774.hdr.sgml : 20160519 20160519172142 ACCESSION NUMBER: 0001209191-16-121774 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160517 FILED AS OF DATE: 20160519 DATE AS OF CHANGE: 20160519 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INVACARE CORP CENTRAL INDEX KEY: 0000742112 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 952680965 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 BUSINESS PHONE: 4403296000 MAIL ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LaPorte Dale C CENTRAL INDEX KEY: 0001314132 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15103 FILM NUMBER: 161664028 MAIL ADDRESS: STREET 1: 1400 MCDONALD INVESTMENT CENTER STREET 2: 800 SUPERIOR AVENUE CITY: CLEVELAND STATE: OH ZIP: 44114 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-05-17 0 0000742112 INVACARE CORP IVC 0001314132 LaPorte Dale C ONE INVACARE WAY ELYRIA OH 44035 1 0 0 0 Common Shares 2016-05-17 4 S 0 375 10.33 D 35697 D Common Shares 20000 I By Trust Stock Option (Right to Buy) Common Shares 7858 7858 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of covering tax obligations arising in connection with the vesting of restricted shares. Includes an aggregate of 9,932 restricted stock units issued pursuant to the Invacare Corporation 2013 Equity Compensation Plan. Owned by the Reporting Person's Rollover IRA. No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5. The reporting person holds previously reported options to buy 7,858 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted on February 12, 2009, at an exercise price of $19.09 per share, will expire on February 12, 2019, and became exercisable between March 31, 2010 and March 31, 2013. /s/ Dale C. LaPorte, by Kristofer K. Spreen, his attorney-in-fact, pursuant to Power of Attorney, dated February 11, 2005, on file with the Commission 2016-05-19